VFF News & Events

Reports Q4 revenue $49.6M, consensus $52.98M. "Our fourth quarter results again delivered strong profitability, gross margin and cash flow from operations which contributed to record levels of performance for each of these metrics in 2025," said CEO Michael DeGiglio. "Thanks to the tireless commitment and execution of our global team, this past year was a transformational one for Village Farms. We are continuing to benefit from multiple catalysts unlocking value for our stakeholders and believe we remain in an excellent position to continue profitably scaling our platform in 2026. We grew global cannabis sales by 17% year-over-year despite just a partial year of contributions from our expanding Netherlands business, and international exports increased more than six-fold as we continue to capitalize on our leadership position among the world's largest EU-GMP certified cannabis operators. We've set a higher standard for our Company on the global stage, and are continuing to invest behind our proven teams with enhancements to our operating capabilities. Demand for our products continues to significantly outpace our current production capacity, and temporary supply constraints coupled with rapidly evolving global regulatory frameworks has created near-term variability in performance as we balance the complex needs of our diverse customer base. In response to higher demand, we are pleased to report that last week we began cultivation in the first half of our previously-announced Delta 2 expansion in Canada, and that this project remains on track to harvest an incremental 15 tonnes of production capacity during the remainder of this year. Our first Netherlands facility continues to operate at full capacity with healthy margin performance, and we are in the process of scaling our local operating team there to support our Phase II facility in Groningen which remains on track for its first grow rooms to be planted at the end of Q1 with the full facility completed and planted by the end of Q2. Once fully ramped, we anticipate annual production capacity of approximately 10 tonnes in the Netherlands, where we continue to see a very strong pricing environment and are well positioned to capture market share in premium product categories. We look to the remainder of 2026 with a growth mindset, and expect to maintain a balanced approach to capital allocation with prudent consideration of accretive organic and acquisitive investments and enhanced value creation for shareholders in the form of ongoing share repurchases. We believe our growth investments, strong net cash position, industry leading cost of capital, and continued solid execution from our teams position us for continued success in 2026 and beyond."

Village Farms International announced the launch of 10 new product offerings in the Netherlands through its wholly-owned subsidiary Leli Holland. "The Company's product portfolio expansion draws on the Company's deep operational expertise and consumer insights from regulated cannabis markets globally, and reflects an intentional focus on format innovation, consumption occasions, and competitive differentiation while aligning with the unique demands of legacy market consumer preferences in the Netherlands," the company said.

Village Farms commended U.S. President Donald Trump for his executive order directing the Attorney General to reschedule marijuana to a Schedule III drug under the Controlled Substances Act. Michael DeGiglio, founder, president, CEO of Village Farms commented, "We commend President Trump for his efforts to overcome decades of policy failures and bureaucratic red tape to advance meaningful reform that will help improve the lives of millions of Americans. We look forward to a better future in the United States in which federal cannabis policy follows scientific and medical research to unlock a new wave of investment and innovation in cannabinoid-based therapeutic products. Earlier this year, Village Farms' legal strategy in the DEA hearing process sought to prevent a failure to reschedule cannabis. We had a unique opportunity to represent our industry in the ALJ proceedings, and we're proud that our actions and advocacy efforts helped contribute to President Trump's thoughtful, evidenced based approach to enacting federal reform. We remain committed to collaborating with policymakers to advance commonsense reform for our seniors, military warriors, veterans, and medical patients, and believe our CBDistillery e-commerce platform, operational capabilities and U.S. production assets can help support increasing demand for safe, affordable medical cannabis products."

Village Farms appointed Brian Stevenson to the role of Global Chief Strategy Officer. Stevenson spent 15 years with British American Tobacco. He later served as Marketing Director for Pharmascience, an international pharmaceutical company. He also co-founded ROSE LifeScience, where he served as CEO and later COO, and conceived, funded, built, and scaled ROSE into one of Canada's leading cannabis companies, with a sizeable presence in Quebec.